Douglas Kerr
CIK 1814189 · Chief Medical Officer · last filed 2026-08-17
Douglas Kerr is a Chief Medical Officer who has filed 33 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $40.9K of DYN on Aug 17, 2026. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.36M
2
33
-$1.76M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Medical Officer | 167,599 | $26.00 | $4.36M | -$210.2K | 12 | 2026-08-17 |
| Generation Bio Co. (GBIO) Delisted | CHIEF MEDICAL OFFICER | 38,563 | $5.34 | $205.9K | -$1.55M | 16 | 2024-01-31 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-17 | DYN | Sell (S) | −1,556 | -$40.9K | EDGAR |
| 2026-08-13 | DYN | Notice (144) | −2,443 | -$64.2K | EDGAR |
| 2026-06-17 | DYN | Sell (S) | −887 | -$16.3K | EDGAR |
| 2026-05-14 | DYN | Sell (S) | −1,564 | -$28.7K | EDGAR |
| 2026-03-06 | DYN | Sell (S) | −904 | -$13.5K | EDGAR |
| 2026-02-17 | DYN | Grant (A) | +85,000 | $0 | EDGAR |
| 2025-12-05 | DYN | Notice (144) | −880 | -$18.2K | EDGAR |
| 2025-12-05 | DYN | Sell (S) | −880 | -$18.2K | EDGAR |
| 2025-09-08 | DYN | Sell (S) | −4,425 | -$58.8K | EDGAR |
| 2025-09-04 | DYN | Notice (144) | −4,552 | -$60.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.